Accuronix Therapeutics is a biotech company that is applying a novel drug-targeting technology to some of the most difficult problems in cancer therapy.

For more information, visit Accuronix Therapeutics.

Locations

Financials

  • $625k

Accuronix Therapeutics Articles

Applied Particle Technology

6 WashU faculty-founded startups show velocity for university business creation

BioGenerator Company Accuronix Targets Pancreatic Cancer